Skip to main content

Heron Therapeutics, Inc 10-Q for FY2026 Q1

Heron Therapeutics, Inc. (HRTX)

10-Q 2026-05-11 For: 2026-03-31
View Original
Added on May 11, 2026

About this 10-Q

Heron Therapeutics, Inc filed this 10-Q on May 11, 2026, covering the quarter ended March 31, 2026 (FY2026 Q1).

Headline figures

Quarter ended March 31, 2026, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue
$34.71M
down 10.8% from $38.9M a year earlier
Net loss
$8.11M
compared with net income of $2.64M a year earlier
Diluted EPS
-$0.04
compared with $0.01 a year earlier